Professor Seamas Donnelly is a graduate of University College Galway (UCG) and completed his respiratory and general medicine training at the Royal Infirmary, Edinburgh. As Lecturer in Respiratory Medicine at the University of Edinburgh he successfully competed for a Wellcome Trust Advanced Fellowship which enabled him to work at the Picower Institute in New York, an internationally renowned research centre affiliated with Rockefeller University.
Professor Donnelly returned to UCD and St. Vincent’s University Hospital in 2001. As Head of Medicine at St. Vincent’s University Hospital he was responsible for the rolling out of the new modular medical curriculum on campus. He is recognized as an international leader in translational medicine and his research epitomizes classical bench to bedside on an international stage. The work of his research group is leading to novel therapies in respiratory disease, particularly in asthma, COPD and sarcoidosis.
He was one of the first clinicians to be awarded a Science Foundation Ireland (SFI) Principal Investigator Programme grant award which was recently renewed for a further five years. This work has focused on the development of novel small molecular-weight anti-inflammatory agents targeting chronic inflammatory diseases particularly pertaining to the lung. He is a co-applicant on the recently awarded Wellcome Trust/HRB Dublin Clinical Research Facility.
In 2010 he was awarded an Honorary Professorship by the University of Edinburgh, The University of Edinburgh is currently ranked among the top 20 universities in the world and following the recent UK Research Assessment Exercise, has been ranked number 1 with regards to medical research. The citation from Edinburgh University recognises Professor Donnelly as an international leader in medical research.
In 2013 he was appointed Editor-in-Chief of the Quarterly Journal of Medicine (QJM), an international medical journal published by Oxford University Press (OUP).